Hughes TR - Search Results

1

Triantafilou M, Hughes TR, Morgan BP, Triantafilou K. Triantafilou M, et al. Among authors: hughes tr. Immunology. 2016 Feb;147(2):152-64. doi: 10.1111/imm.12556. Immunology. 2016. PMID: 26572245 Free PMC article. Review.

2

Isolation and characterization of a membrane protein from rat erythrocytes which inhibits lysis by the membrane attack complex of rat complement.

Hughes TR, Piddlesden SJ, Williams JD, Harrison RA, Morgan BP. Hughes TR, et al. Biochem J. 1992 May 15;284 ( Pt 1)(Pt 1):169-76. doi: 10.1042/bj2840169. Biochem J. 1992. PMID: 1376109 Free PMC article.

3

Immunolocalization and characterization of the rat analogue of human CD59 in kidney and glomerular cells.

Hughes TR, Meri S, Davies M, Williams JD, Morgan BP. Hughes TR, et al. Immunology. 1993 Nov;80(3):439-44. Immunology. 1993. PMID: 7507093 Free PMC article.

4

Complement regulator loss on apoptotic neuronal cells causes increased complement activation and promotes both phagocytosis and cell lysis.

Cole DS, Hughes TR, Gasque P, Morgan BP. Cole DS, et al. Among authors: hughes tr. Mol Immunol. 2006 May;43(12):1953-64. doi: 10.1016/j.molimm.2005.11.015. Epub 2006 Jan 10. Mol Immunol. 2006. PMID: 16406094

5

p53 regulates cellular resistance to complement lysis through enhanced expression of CD59.

Donev RM, Cole DS, Sivasankar B, Hughes TR, Morgan BP. Donev RM, et al. Among authors: hughes tr. Cancer Res. 2006 Feb 15;66(4):2451-8. doi: 10.1158/0008-5472.CAN-05-3191. Cancer Res. 2006. Retraction in: Cancer Res. 2013 Nov 15;73(22):6838. doi: 10.1158/0008-5472.CAN-13-2935 PMID: 16489052 Free article. Retracted.

6

CD59a deficient mice display reduced B cell activity and antibody production in response to T-dependent antigens.

Sivasankar B, Donev RM, Longhi MP, Hughes TR, Davies R, Cole DS, Morgan BP, Marchbank KJ. Sivasankar B, et al. Among authors: hughes tr. Mol Immunol. 2007 Apr;44(11):2978-87. doi: 10.1016/j.molimm.2006.12.025. Epub 2007 Feb 12. Mol Immunol. 2007. PMID: 17296227

7

Modulation of CD59 expression by restrictive silencer factor-derived peptides in cancer immunotherapy for neuroblastoma.

Donev RM, Gray LC, Sivasankar B, Hughes TR, van den Berg CW, Morgan BP. Donev RM, et al. Among authors: hughes tr. Cancer Res. 2008 Jul 15;68(14):5979-87. doi: 10.1158/0008-5472.CAN-07-6828. Cancer Res. 2008. Retraction in: Cancer Res. 2013 Nov 15;73(22):6839. doi: 10.1158/0008-5472.CAN-13-2936 PMID: 18632654 Free PMC article. Retracted.

8

Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury.

Ruseva MM, Hughes TR, Donev RM, Sivasankar B, Pickering MC, Wu X, Harris CL, Morgan BP. Ruseva MM, et al. Among authors: hughes tr. Mol Immunol. 2009 Feb;46(5):803-11. doi: 10.1016/j.molimm.2008.09.003. Epub 2008 Oct 22. Mol Immunol. 2009. PMID: 18947875

9

Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.

Hughes TR, Ross KS, Cowan GJ, Sivasankar B, Harris CL, Mitchell TJ, Morgan BP. Hughes TR, et al. Mol Immunol. 2009 Apr;46(7):1561-7. doi: 10.1016/j.molimm.2009.01.003. Epub 2009 Feb 6. Mol Immunol. 2009. PMID: 19200600 Free PMC article.

10

The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout mice.

Lewis RD, Jackson CL, Morgan BP, Hughes TR. Lewis RD, et al. Among authors: hughes tr. Mol Immunol. 2010 Feb;47(5):1098-105. doi: 10.1016/j.molimm.2009.10.035. Epub 2009 Dec 2. Mol Immunol. 2010. PMID: 19959238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters